Data availability
The data in this study are available from the corresponding author upon reasonable request.
References
Jäger U, Barcellini W, Broome CM et al (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults Recommendations from the First International Consensus Meeting. Blood Rev 41:100648. https://doi.org/10.1016/j.blre.2019.100648
Imoto H, Yoshioka S, Nakagawa D et al (2022) Cold agglutinin anti-I antibodies in two patients with COVID-19. J Clin Lab Anal 36:e24629. https://doi.org/10.1002/jcla.24629
Randen U, Troen G, Tierens A et al (2014) Primary cold agglutinin-associated lymphoproliferative disease: A B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica 99:497–504. https://doi.org/10.3324/haematol.2013.091702
Haghi N, Roy S, Laser J et al (2014) Primary chronic cold agglutinin disease associated with CD5-positive monoclonal B-cell lymphocytosis of undetermined significance and monoclonal IGVH3–64 gene rearrangement. Am J Clin Pathol 142. https://doi.org/10.1093/ajcp/142.suppl1.117
Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36:1720–1748. https://doi.org/10.1038/s41375-022-01620-2
Wollina U, Koch A, Langner D et al (2018) Acrocyanosis - A symptom with many facettes. Open Access Maced J Med Sci 6:208–212. https://doi.org/10.3889/oamjms.2018.035
Rawstron AC, Bennett FL, O’Connor SJ et al (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359:575–583. https://doi.org/10.1056/NEJMoa075290
Rawstron AC, Green MJ, Kuzmick iA et al (2002) Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 100:635–639. https://doi.org/10.1182/blood.v100.2.635
Berentsen S, Barcellini W, D’Sa S et al (2020) Cold agglutinin disease revisited a multinational, observational study of 232 patients. Blood 136:480–488. https://doi.org/10.1182/blood.2020005674
Jalink M, Berentsen S, Castillo JJ et al (2021) Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome. Blood 138:2002–2005. https://doi.org/10.1182/blood.2021012039
Acknowledgements
We thank Shogo Goto for performing a direct agglutination test. The manuscript was edited and proofread by Editage (https://www.editage.jp/).
Author information
Authors and Affiliations
Contributions
W.K. collected clinical and histological data and wrote the original draft. H.K. performed review and editing. A.I. performed histological diagnosis. H.W., Y.M., and S.K. performed supervision, review, and editing. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Consent for publication
A written informed consent was obtained from the patient for the publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kitamura, W., Kobayashi, H., Iseki, A. et al. Cold agglutinin–induced acrocyanosis without hemolytic anemia. Ann Hematol 103, 681–683 (2024). https://doi.org/10.1007/s00277-023-05538-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05538-2